VeriMomsodium c12-15 pareth-7 sulfonate hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive warning found for sodium C12–15 pareth-7 sulfonate. Regulatory and safety-assessment sources treat ethoxylated alkyl sulfonate surfactants as low systemic-reprotoxicity in cosmetic use (CIR / SCCS style conclusions) and there are no peer-reviewed reports of teratogenicity or human reproductive effects for this specific ingredient. Dermal cosmetic use can give low but measurable exposure; therefore exposure score is 1. Sources: ECHA Annex VI (no harmonised classification), CIR/SCCS style safety literature, PubChem/CosIng entries (no reproductive flags).
Related ingredients
Frequently asked questions
- sodium c12-15 pareth-7 sulfonate hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive warning found for sodium C12–15 pareth-7 sulfonate. Regulatory and safety-assessment sources treat ethoxylated alkyl sulfonate surfactants as low systemic-reprotoxicity in cosmetic use (CIR / SCCS style conclusions) and there are no peer-reviewed reports of teratogenicity or human reproductive effects for this specific ingredient. Dermal cosmetic use can give low but measurable exposure; therefore exposure score is 1. Sources: ECHA Annex VI (no harmonised classification), CIR/SCCS style safety literature, PubChem/CosIng entries (no reproductive flags).
- sodium c12-15 pareth-7 sulfonate emzirirken güvenli mi?
- No evidence of reproductive or lactation-related toxicity or known mechanisms for transfer into breast milk for this ingredient; no harmonised hazard classification. Dermal cosmetic use implies low but measurable maternal systemic exposure, so a low exposure score is used. Sources: ECHA records (no harmonised classification), CosIng/PubChem (no lactation concerns), absence of CIR/SCCS warnings.
- sodium c12-15 pareth-7 sulfonate bebek cildi için güvenli mi?
- No infant-specific reproductive or developmental hazards identified for this surfactant. However, immature infant skin has higher permeability and higher surface-area-to-weight, so exposure score is increased by +1 from adult (adult e=1 → infant e=2). No infant-specific adverse data found in regulatory or peer-reviewed sources. Sources: CosIng/PubChem (ingredient identity and typical use), ECHA (no harmonised classification), toxicology literature absence per CIR/SCCS practice.
- VeriMom sodium c12-15 pareth-7 sulfonate nasıl puanlıyor?
- VeriMom sodium c12-15 pareth-7 sulfonate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte sodium c12-15 pareth-7 sulfonate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.